Literature DB >> 25711253

Cutaneous leukocytoclastic vasculitis associated with anti-tuberculosis drugs.

Gülhadiye Avcu1, Gülnar Sensoy, Mehmet Halil Çeliksoy, Ayhan Sogut, Mehmet Kefeli, Arzu Karli, Nursen Belet.   

Abstract

Leukocytoclastic vasculitis (LCV), a disease characterized by inflammation of the small vessels, presents with palpable purpura, especially in the lower extremities. Its etiology is known to include drugs, infection, collagen tissue disease, and malignancy, but LCV caused by anti-tuberculosis drugs is very rarely seen. This report describes the case of a 12-year-old girl who developed LCV with rifampicin and ethambutol while undergoing anti-tuberculosis treatment due to extensive pulmonary involvement.
© 2015 Japan Pediatric Society.

Entities:  

Keywords:  anti-tuberculosis drug; ethambutol; leukocytoclastic vasculitis; rifampicin

Mesh:

Substances:

Year:  2015        PMID: 25711253     DOI: 10.1111/ped.12403

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  3 in total

1.  Cutaneous Leukocytoclastic Vasculitis with Gastrointestinal Involvement after Anti-Tuberculosis Treatment.

Authors:  Sangwoo Shim; Chi Young Jung
Journal:  Tuberc Respir Dis (Seoul)       Date:  2017-03-31

2.  Versatile TLC-Densitometric Methods for the Synchronous Estimation of Cinnarizine and Acefylline Heptaminol in The Presence of Potential Impurity and Their Reported Degradation Products.

Authors:  Ola M El-Houssini; Mohammad A Mohammad
Journal:  J Chromatogr Sci       Date:  2021-12-08       Impact factor: 1.618

3.  A not-so-sweet diagnosis - leukocytoclastic vasculitis masquerading as squamous cell carcinoma.

Authors:  Mussa Mensa; Zita M Jessop; Nick Wilson-Jones; Iain S Whitaker
Journal:  Int Wound J       Date:  2016-09-29       Impact factor: 3.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.